In addition, stratified analyses have identified sets of interactions and compound genotypes in the APOE locus of the ε2- and ε4-carriers, which may modify the effects of these alleles on AD risk and, to some extent, justify their incomplete penetrance (Nazarian et al., 2022a,b). The gene discussed is APOE; the disease is Alzheimer disease.